Our Technology

What we do

We believe in biological plausibility and faithful representations.
The core of our technology is based on extracting the semantics that govern biological interactions using machine learning and massive amounts of public and proprietary data.

Our state-of-the-art machine learning algorithms utilize multi-omic data structures to create causal representations of the biological events leading to disease onset.
Not only are our models accurate and comprehensive, they are also transparent, providing explainable predictions and allowing researchers to investigate specific pathways that define disease and health.

Simulations of physiological events are further supported by real world evidence from existing clinical trials. The Simmunome platform is also structured to integrate new emerging data to ensure we stay at the forefront of cutting-edge research.

This moment in medicine is only now possible thanks to the advances in AI in the last 6 years. We believe we are at the edge of a significant shift in how we diagnose and treat patients. We know that a “one-size-fits-all” approach is no longer viable, given our understading and increasing appreciation of patient diferences across a single disease type. Now we can do better with the ability to go to n of 1 specificity. Precision medicine is about to become standard of care.

How We Help You

Novel Drug Targets

  • Identify and validate novel molecules.
  •  Guide your indication strategy.
  •  Drug re-purposing.

Clinical Trial Simulations

  • Predict probability of success/failure of a drug target.
  • Simulate clinical trial safety and efficacy outcomes.
  • Optimize trial design (e.g., dose selection, endpoints, assessment schedules).

Therapeutic and Diagnostic Investigations

  • Identify and validate biomarkers for diagnosis
  •  Patient stratification
  • Personalize treatments
  • Identify at-risk populations
Pipette and Vial

We are building our library of disease models. While each baseline model is based on a corpus of public, peer-reviewed data, we can further customize each one by enriching them with your proprietary data will further enhance their predictability. Don’t see your therapeutic area listed here? We can build disease models to align with your pipeline. Through every phase of clinical development we are there to support you on your path to regulatory approaval.


  • Breast cancer
  • Colorectal cancer
  • Non-small cell lung cancer
  • Prostate cancer
  • Melanoma
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Tissue repair